Middlebrook

In November 2007, Middlebrook was on the verge of receiving FDA approval for its once daily, pulsed amoxicillin capsule. However, given the economic environment they were unable to access capital needed to finance ongoing operations. Deerfield provided $10 million to finance Middlebrook’s operating expenses.